These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25019423)

  • 41. Evaluation of proteomics-identified CCL18 and CXCL1 as circulating tumor markers for differential diagnosis between ovarian carcinomas and benign pelvic masses.
    Wang Q; Li D; Zhang W; Tang B; Li QQ; Li L
    Int J Biol Markers; 2011; 26(4):262-73. PubMed ID: 21928244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum sICAM-1 (soluble intercellular adhesion molecule-1) and M-CSF (macrophage colony-stimulating growth factor) throughout monitoring of 34 non-serous ovarian cancers.
    Callet N; Delaunay J; Pichon MF
    Eur J Gynaecol Oncol; 2000; 21(2):135-40. PubMed ID: 10843471
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.
    Lea J; Sharma R; Yang F; Zhu H; Ward ES; Schroit AJ
    Oncotarget; 2017 Feb; 8(9):14395-14407. PubMed ID: 28122335
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The diagnostic value of determination of serum GOLPH3 associated with CA125, CA19.9 in patients with ovarian cancer.
    Fan HY; Duan DM; Liu YF
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4039-4044. PubMed ID: 29028099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative CA-125 Values as a Predictive Factor for the Postoperative Outcome in Primary Serous Ovarian Cancer.
    Muallem MZ; Parashkevova A; Almuheimid J; Richter R; Diab Y; Braicu EI; Sehouli J
    Anticancer Res; 2017 Jun; 37(6):3157-3161. PubMed ID: 28551658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
    Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of serum CCL18 as a potential biomarker for ovarian cancer.
    Yuan L; Wan J; Huang C; Liang J; Liu M; Yue C; Li L
    Cancer Biomark; 2017 Dec; 21(1):97-104. PubMed ID: 29036787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum levels of epidermal growth factor, transforming growth factor, and c-erbB2 in ovarian cancer.
    Balcan E; Demirkiran F; Aydin Y; Sanioglu C; Bese T; Arvas M; Akçay T; Cift T
    Int J Gynecol Cancer; 2012 Sep; 22(7):1138-42. PubMed ID: 22914212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soluble tumor necrosis factor receptors and CA 125 in serum as markers for epithelial ovarian cancer.
    Onsrud M; Shabana A; Austgulen R
    Tumour Biol; 1996; 17(2):90-6. PubMed ID: 8658018
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Validation and characterization of human kallikrein 11 as a serum marker for diagnosis of ovarian carcinoma.
    McIntosh MW; Liu Y; Drescher C; Urban N; Diamandis EP
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4422-8. PubMed ID: 17671125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential role for nectin-4 in the pathogenesis of pre-eclampsia: a molecular genetic study.
    Ito M; Nishizawa H; Tsutsumi M; Kato A; Sakabe Y; Noda Y; Ohwaki A; Miyazaki J; Kato T; Shiogama K; Sekiya T; Kurahashi H; Fujii T
    BMC Med Genet; 2018 Sep; 19(1):166. PubMed ID: 30217189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preoperative serum vascular endothelial growth factor (VEGF) in ovarian masses.
    Tanir HM; Ozalp S; Yalcin OT; Colak O; Akcay A; Senses T
    Eur J Gynaecol Oncol; 2003; 24(3-4):271-4. PubMed ID: 12807238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TATI (tumour-associated trypsin inhibitor) as a marker of ovarian cancer.
    Medl M; Ogris E; Peters-Engl C; Leodolter S
    Br J Cancer; 1995 May; 71(5):1051-4. PubMed ID: 7734298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients].
    Lyu N; Yao H; Xiao T; Gao Y; Wu L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):679-84. PubMed ID: 26675395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secretome Identifies Tenascin-X as a Potent Marker of Ovarian Cancer.
    Kramer M; Pierredon S; Ribaux P; Tille JC; Petignat P; Cohen M
    Biomed Res Int; 2015; 2015():208017. PubMed ID: 26090390
    [TBL] [Abstract][Full Text] [Related]  

  • 56. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
    El Sherbini MA; Mansour AA; Sallam MM; Shaban EA; Shehab ElDin ZA; El-Shalakany AH
    J Ovarian Res; 2018 Apr; 11(1):32. PubMed ID: 29690914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum HE4 as a useful biomarker in discriminating ovarian cancer from benign pelvic disease.
    Zheng H; Gao Y
    Int J Gynecol Cancer; 2012 Jul; 22(6):1000-5. PubMed ID: 22426406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nidogen-1: a candidate biomarker for ovarian serous cancer.
    Li L; Zhang Y; Li N; Feng L; Yao H; Zhang R; Li B; Li X; Han N; Gao Y; Xiao T; Wu L
    Jpn J Clin Oncol; 2015 Feb; 45(2):176-82. PubMed ID: 25378651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.
    Lehtinen L; Vesterkvist P; Roering P; Korpela T; Hattara L; Kaipio K; Mpindi JP; Hynninen J; Auranen A; Davidson B; Haglund C; Iljin K; Grenman S; Siitari H; Carpen O
    PLoS One; 2016; 11(3):e0151590. PubMed ID: 26981633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of whether serum tumor markers in patients with epithelial ovarian carcinoma change following chemotherapy.
    Li XP; Xu QY; Wang JL; Wang SJ; Zhao Y; Wei LH
    Chin Med J (Engl); 2012 Feb; 125(3):410-5. PubMed ID: 22490394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.